+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

China Women Health Diagnostics Market 2019-2025

  • ID: 5124690
  • Report
  • March 2020
  • Region: China
  • Orion Market Research Private Limited

FEATURED COMPANIES

  • Abbott Laboratories, Inc.
  • Becton, Dickson and Co.
  • biomerieux SA
  • F. Hoffmann-La Roche Ltd.
  • Fujifilm Holdings Corp.
  • General Electric Co.
China Women Health Diagnostics Market Size, Share & Trends Analysis Report by Application (Breast Cancer Testing, Cervical Cancer Testing, Pregnancy & Fertility Testing, Ovarian Cancer Testing, Infectious Disease Testing, Ultrasound Tests, Sexually Transmitted Disease Testing, and Others (Osteoporosis Testing and Prenatal Genetic Testing)), and by End-User (Diagnostic and Imaging Centers, Hospitals and Clinics, and Home Care) Forecast Period 2019-2025.

China women health diagnostics market is growing at a CAGR of approximately 10.0% during the forecast period. China is one of the major countries in the women healthcare diagnostics market. China is one of the fastest-growing economies of the world with a GDP of over $21.3 trillion, with around $ 15,400 per capita. Increasing healthcare infrastructure in China is one of the major factors that is driving the growth of the China women health diagnostics market. Total per capita expenditure in China was estimated to be around 5.5% of the overall GDP of the country. All major cities have hospitals and healthcare centers specializing in various fields and are equipped with some modern facilities. These are the major factors that are backing the growth of the china women health diagnostic market during the forecast period.

Further, cancer incidences and mortality have been augmented in China, making cancer a major public health problem in the country and the leading cause of mortality since the last decade. This rising burden is caused by the overgrowing population, sociodemographic changes. According to CDC, it is estimated that there will be about 4.3 million new cancer cases and 2.9 million new cancer deaths were recorded in 2018 in China, which can be prevented by early detection and treatment. Among women, the most common cancers are lung and bronchus, stomach, colorectal, breast, and esophagus, accounting for around 60% of all cases. Breast cancer alone is anticipated to account for 15% of all new cancers in women in China. Thus, all these factors lead to the growth of the China women health diagnostic market during the forecast period.

Research Methodology

The market study of the China Women Health Diagnostics market is incorporated by extensive primary and secondary research conducted by the research team. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. The team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors.

Numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables the analyst to derive the closest possible figures without any major deviations in the actual number. The analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to the reports.

Secondary Sources Include:
  • Financial reports of companies involved in the market.
  • Whitepapers, research-papers, and news blogs.
  • Company websites and their product catalog.

The report provides an in-depth analysis of market size, intended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models.

Market Segmentation:

1. China Women Health Diagnostics Market Research and Analysis by Application
2. China Women Health Diagnostics Market Research and Analysis by End-user

The Report covers:
  • Comprehensive research methodology of the China Women Health Diagnostics market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the China Women Health Diagnostics market.
  • Insights about market determinants which are stimulating the China Women Health Diagnostics market.
  • Detailed and extensive market segments with regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Abbott Laboratories, Inc.
  • Becton, Dickson and Co.
  • biomerieux SA
  • F. Hoffmann-La Roche Ltd.
  • Fujifilm Holdings Corp.
  • General Electric Co.
1. Report Summary
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments

2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
2.3. Rules & Regulations

3. Competitive Landscape
3.1. Company Share Analysis
3.2. Key Strategy Analysis
3.3. Key Company Analysis
3.3.1. Overview
3.3.2. Financial Analysis
3.3.3. SWOT Analysis
3.3.4. Recent Developments

4. Market Determinants
4.1. Motivators
4.2. Restraints
4.3. Opportunities

5. Market Segmentation
5.1. China Women Health Diagnostics Market by Applications
5.1.1. Breast Cancer Testing
5.1.2. Cervical Cancer Testing
5.1.3. Pregnancy & Fertility Testing
5.1.4. Ovarian Cancer Testing
5.1.5. Infectious Disease Testing
5.1.6. Ultrasound Tests
5.1.7. Sexually Transmitted Disease Testing
5.1.8. Others (Osteoporosis Testing and Prenatal Genetic Testing)
5.2. China Women Health Diagnostics Market by End-User
5.2.1. Diagnostic and Imaging Centers
5.2.2. Hospitals and Clinics
5.2.3. Home Care

6. Company Profiles
6.1. Abbott Laboratories, Inc.
6.2. Becton, Dickson and Co.
6.3. biomerieux SA
6.4. EKF Diagnostics Holdings PLC
6.5. F. Hoffmann-La Roche Ltd.
6.6. Fujifilm Holdings Corp.
6.7. General Electric Co.
6.8. Hologic, Inc.
6.9. Koninklijke Philips N.V.
6.10. Luminex Corp.
6.11. QIAGEN N.V.
6.12. Siemens AG
6.13. Thermo Fisher Scientific Inc.

LIST OF TABLES
1. CHINA WOMEN HEALTH DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2018-2025 ($ MILLION)
2. CHINA WOMEN HEALTH DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY END-USER, 2018-2025 ($ MILLION)

LIST OF FIGURES
1. CHINA WOMEN HEALTH DIAGNOSTICS MARKET SHARE BY APPLICATION, 2018 VS 2025 (%)
2. CHINA WOMEN HEALTH DIAGNOSTICS MARKET SHARE BY END-USER, 2018 VS 2025 (%)
Note: Product cover images may vary from those shown

A selection of companies mentioned in this report includes:

  • Abbott Laboratories, Inc.
  • Becton, Dickson and Co.
  • biomerieux SA
  • EKF Diagnostics Holdings PLC
  • F. Hoffmann-La Roche Ltd.
  • Fujifilm Holdings Corp.
  • General Electric Co.
  • Hologic, Inc.
  • Koninklijke Philips N.V.
  • Luminex Corp.
  • QIAGEN N.V.
  • Siemens AG
  • Thermo Fisher Scientific Inc.
Note: Product cover images may vary from those shown